Mezilamine is a potent antidopaminergic agent. Mezilamine induces a concentration dependent increase in the electrically stimulated overflow of 3H-noradrenaline from rat cortical slices, without affecting the basal overflow. Mezilamine acts as a presynaptic alpha-adrenoceptor antagonist and a postsynaptic alpha-adrenoceptor agonist[1].
Molecular Weight:
287.81
CAS Number:
[50335-55-2]
Formula:
C11H18ClN5S
Target:
Adrenergic Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted